International Journal of Clinical Research
International Journal of Clinical Research. 2023; 7: (1) ; 10.12208/j.ijcr.20230042 .
总浏览量: 313
雅安职业技术学院附属医院 四川雅安
*通讯作者： 蒋图彬,单位：雅安职业技术学院附属医院 四川雅安；
目的 评估布地奈德混悬液雾化吸入治疗对急性咽喉炎临床效果与安全性。方法 方便撷取2021年1月至2022年7月时段内就本院行急性咽喉炎治疗的患者118例，依据SPSS22.0软件生成随机分组序列后均分为两组；分别予清开灵颗粒与布地奈德混悬液雾化吸入治疗。判别比对两组症状缓解时间、血清炎症因子以及临床效果。结果 治疗后，观察组2项炎症指标均低于对照组（P<0.001），咽痛、咳嗽以及声嘶咽痒消失时间均短于对照组（P<0.001），总体疗效（96.61%）高于对照组（83.05%）（P<0.05）。结论 针对急性咽喉炎予以布地奈德混悬液雾化吸入效果优异，整体安全性较高。
Objective: To evaluate the clinical efficacy and safety of budesonide suspension aerosol inhalation in the treatment of acute pharyngitis. Methods: From January 2021 to July 2022, 118 patients with acute pharyngolaryngitis in our hospital were collected and randomly divided into two groups according to SPSS 22.0 software; Qingkailing granules and budesonide suspension were inhaled respectively. The symptom relief time, serum inflammatory factors and clinical effects of the two groups were compared. Results: After treatment, the three inflammatory indexes in the observation group were lower than those in the control group (P<0.001), and the disappearance time of pharyngodynia, cough and hoarseness and itching was shorter than that in the control group (P<0.001). The overall efficacy (96.61%) was higher than that in the control group (83.05%) (P<0.05). Conclusion : The atomization inhalation of budesonide suspension for acute pharyngitis is effective and safe.
[1] 符牧,程钢,杨中川,等.布地奈德联合地塞米松雾化吸入治疗急性感染性咽喉炎的临床研究[J].中国临床药理学杂志, 2019,35(23):3013-3016.
[2] 李苗,魏宁漪,郑静,等.吸入用布地奈德混悬液的体外雾化特性[J]. 药学学报, 2021,56(10):2669-2675.
[3] 陈余思,白碧慧,胡强,等.布地奈德混悬液联合沙丁胺醇雾化吸入治疗支气管哮喘的疗效及对炎症因子水平的影响[J].现代生物医学进展, 2021,21(13):2597-2600.
[4] 潘杰.布地奈德混悬液雾化吸入治疗咽炎合并声带水肿的疗效[J].中国医药指南, 2019,17(17):119-120.
[5] 杨小营.布地奈德混悬液雾化吸入治疗急性咽喉炎临床效果观察[J]. 中国现代药物应用, 2020,14(4):122-123.